amitriptyline has been researched along with Cardiac Conduction Defect in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, RS | 1 |
| Mayuga, KA | 1 |
| Gabbard, S | 1 |
| KRISTJANSEN, P | 1 |
| POULSEN, H | 1 |
2 other studies available for amitriptyline and Cardiac Conduction Defect
| Article | Year |
|---|---|
Management of an Unusual Case of Dysphagia.
Topics: Amitriptyline; Cardiac Conduction System Disease; Deglutition Disorders; Diagnosis, Differential; Hu | 2020 |
[Bundle-branch block as a side effect in amitriptyline treatment].
Topics: Amitriptyline; Antidepressive Agents; Bundle-Branch Block; Cardiac Conduction System Disease; Heart | 1963 |